Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2018 1
2020 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Molecular cancer phenotype in normal prostate tissue.
Schlomm T, Hellwinkel OJ, Buness A, Ruschhaupt M, Lübke AM, Chun FK, Simon R, Budäus L, Erbersdobler A, Graefen M, Huland H, Poustka A, Sültmann H. Schlomm T, et al. Among authors: lubke am. Eur Urol. 2009 Apr;55(4):885-90. doi: 10.1016/j.eururo.2008.04.105. Epub 2008 May 16. Eur Urol. 2009. PMID: 18501497
Loss of p16 and high Ki67 labeling index is associated with poor outcome in esophageal carcinoma.
Jacobsen F, Kohsar J, Gebauer F, Kluth M, Hube-Magg C, Simon R, Bockhorn M, Hinsch A, Burandt E, Lübke AM, Steurer S, Tachezy M, Sauter G, Izbicki JR, Wilczak W, Melling N. Jacobsen F, et al. Among authors: lubke am. Oncotarget. 2020 Mar 24;11(12):1007-1016. doi: 10.18632/oncotarget.27507. eCollection 2020 Mar 24. Oncotarget. 2020. PMID: 32256975 Free PMC article.
Deletion of 3p13 is a late event linked to progression of TMPRSS2:ERG fusion prostate cancer.
Kluth M, Volta H, Hussein M, Taskin B, Frogh S, Möller-Koop C, Büscheck F, Jacobsen F, Tsourlakis MC, Lübke AM, Hinsch A, Clauditz T, Graefen M, Heinzer H, Huland H, Minner S, Sauter G, Wilczak W, Schlomm T, Simon R. Kluth M, et al. Among authors: lubke am. Cancer Manag Res. 2018 Nov 19;10:5909-5917. doi: 10.2147/CMAR.S172637. eCollection 2018. Cancer Manag Res. 2018. PMID: 30510458 Free PMC article.
Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence.
Kind S, Kluth M, Hube-Magg C, Möller K, Makrypidi-Fraune G, Lutz F, Lennartz M, Rico SD, Schlomm T, Heinzer H, Höflmayer D, Weidemann S, Uhlig R, Huland H, Graefen M, Bernreuther C, Tsourlakis MC, Minner S, Dum D, Hinsch A, Lübke AM, Simon R, Sauter G, Marx A, Polonski A. Kind S, et al. Among authors: lubke am. Biomed Res Int. 2020 Oct 28;2020:5845374. doi: 10.1155/2020/5845374. eCollection 2020. Biomed Res Int. 2020. PMID: 33195694 Free PMC article.